Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48,507,463
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
18,982,797
-
Shares change
-
-124,933
-
Total reported value, excl. options
-
$83,522,100
-
Value change
-
-$5,015,169
-
Number of buys
-
21
-
Number of sells
-
24
-
Price
-
$4.40
Institutional Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q1 2022
As of 31 Mar 2022 Werewolf Therapeutics, Inc. - Common Stock (HOWL) had 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,982,797 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., MPM ASSET MANAGEMENT LLC, BIOIMPACT CAPITAL LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), DC Funds, LP, PFM Health Sciences, LP, SPHERA FUNDS MANAGEMENT LTD., and VANGUARD GROUP INC.
This table shows 57 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.